Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac at Lower Doses for Analgesic Pain Control in ICU
NCT06819956Phase 3Recruiting
- Sponsor
- University of Alberta
- Start
- Jun 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketorolac in pain, sponsored by University of Alberta. Started Jun 2025; status: recruiting.
02
Drugs
ketorolac
03
Conditions
pain
Beyond the preview
Go deeper on NCT06819956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06819956.